Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review
Publication type: Journal Article
Publication date: 2018-06-01
SJR: —
CiteScore: —
Impact factor: —
ISSN: 24443824
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Journal of Pharmacy Practice and Research
1 publication, 50%
|
|
|
1
|
Publishers
|
1
|
|
|
Wiley
1 publication, 50%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2
Total citations:
2
Citations from 2024:
0
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Gisbert J. P., Chaparro M. Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review // Gastroenterología y Hepatología (English Edition). 2018. Vol. 41. No. 6. pp. 389-405.
GOST all authors (up to 50)
Copy
Gisbert J. P., Chaparro M. Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review // Gastroenterología y Hepatología (English Edition). 2018. Vol. 41. No. 6. pp. 389-405.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.gastre.2018.04.019
UR - https://doi.org/10.1016/j.gastre.2018.04.019
TI - Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review
T2 - Gastroenterología y Hepatología (English Edition)
AU - Gisbert, Javier P
AU - Chaparro, María
PY - 2018
DA - 2018/06/01
PB - Elsevier
SP - 389-405
IS - 6
VL - 41
SN - 2444-3824
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2018_Gisbert,
author = {Javier P Gisbert and María Chaparro},
title = {Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review},
journal = {Gastroenterología y Hepatología (English Edition)},
year = {2018},
volume = {41},
publisher = {Elsevier},
month = {jun},
url = {https://doi.org/10.1016/j.gastre.2018.04.019},
number = {6},
pages = {389--405},
doi = {10.1016/j.gastre.2018.04.019}
}
Cite this
MLA
Copy
Gisbert, Javier P., and María Chaparro. “Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review.” Gastroenterología y Hepatología (English Edition), vol. 41, no. 6, Jun. 2018, pp. 389-405. https://doi.org/10.1016/j.gastre.2018.04.019.